Sphaera Pharma

Gurugram, India Founded: 2007 • Age: 19 yrs
Specialty company engaged in drug discovery and development
Annual revenue $934,377 Latest available
Total funding $10.0M 2 rounds
Employees 35 Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Sphaera Pharma

Sphaera Pharma is a company based in Gurugram (India) founded in 2007. Sphaera Pharma has raised $10 million across 2 funding rounds from investors including Wellcome and Baring Private Equity Partners. The company has 35 employees as of March 31, 2024.

  • Headquarter Gurugram, India
  • Employees 35 as on 31 Mar, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $934.38 K (USD)
    6
    as on Mar 31, 2024
  • Net Profit
    $2.78 K (USD)
    100
    as on Mar 31, 2024
  • EBITDA
    $29.94 K (USD)
    102
    as on Mar 31, 2024
  • Total Equity Funding
    $10 M (USD)

    in 2 rounds

  • Latest Funding Round
    Not available
  • Investors
    Wellcome

    & 1 more

  • Employee Count
    35

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Sphaera Pharma

Headcount 50-200
Employee Profiles 2
Employee Profiles
People
Abhinav D.
Chief Executive Officer

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Sphaera Pharma

Sphaera Pharma has successfully raised a total of $10M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Sphaera Pharma

Sphaera Pharma has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Wellcome and Baring Private Equity Partners.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity firm focusing on buyouts and investments in multiple sectors
Locked Locked Locked
Health research and advocacy are funded globally by the foundation.
Locked Locked Locked
Premium access

Investor details for Sphaera Pharma

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sphaera Pharma

Investments
Premium access

Investment portfolio details for Sphaera Pharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Sphaera Pharma

Premium access

Detailed financials for Sphaera Pharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Sphaera Pharma Comparisons

Sphaera Pharma Primary company
Description
Specialty company engaged in drug discovery and development
Location
Gurugram, India
Founded Year
2007
Annual Revenue
$934.38 K (USD)
Net Profit
$2.78 K (USD)
EBITDA
$29.94 K (USD)
Employees
35
As of 2024
Premium access

Peer comparison for Sphaera Pharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Sphaera Pharma

Premium access

Detailed competitors of Sphaera Pharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Sphaera Pharma

Premium access

Complete news archive for Sphaera Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sphaera Pharma

Sphaera Pharma was founded in 2007 and raised its 1st funding round 1 year after it was founded.

Sphaera Pharma is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.

Sphaera Pharma is a funded company, having raised a total of $10M across 2 funding rounds to date.

As of Mar 31, 2024, the latest employee count at Sphaera Pharma is 35.

Annual revenue of Sphaera Pharma is $934.38K as on Mar 31, 2024.

Sphaera Pharma is engaged in drug discovery and development activities. All research programs are based on translational research. Sphaera has established a patent portfolio that includes repurposing of drugs, a potential solution focused on cancer metastasis, methodology that allows for designing therapies using current drugs to address resistant cancers, and potential treatment for multi-drug resistant infections Since, 2009, the company claims to have filed 28 patents. The pipeline includes a portfolio of 9 products in various preclinical and clinical stages.

Sphaera Pharma has 2 investors. Key investors include Wellcome, and Baring Private Equity Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available